Validation of genetic risk scores for obesity on a sample of the population of Russian regions

A. Kiseleva, A. G. Soplenkova, V. Kutsenko, E. Sotnikova, Yu.V. Vyatkin, А. A. Zharikova, A. Ershova, M. Zaichenoka, V. Ramensky, O. Skirko, S. Smetnev, O. Kopylova, А. S. Limonova, A. Blokhina, M. S. Pokrovskaya, S. Shalnova, A. N. Meshkov, O. Drapkina
{"title":"Validation of genetic risk scores for obesity on a sample of the population of Russian regions","authors":"A. Kiseleva, A. G. Soplenkova, V. Kutsenko, E. Sotnikova, Yu.V. Vyatkin, А. A. Zharikova, A. Ershova, M. Zaichenoka, V. Ramensky, O. Skirko, S. Smetnev, O. Kopylova, А. S. Limonova, A. Blokhina, M. S. Pokrovskaya, S. Shalnova, A. N. Meshkov, O. Drapkina","doi":"10.15829/1728-8800-2023-3755","DOIUrl":null,"url":null,"abstract":"Aim. To validate and evaluate the accuracy of 15 genetic risk scores (GRSs) for obesity, created in populations of European origin in the sample of two European Russia regions. Material and methods. Genetic testing has been performed using next generation sequencing on a sample from the Russian population (n=1179). The study included 15 GRS associated with body mass index (BMI) or waist-to-hip ratio adjusted for BMI (WHRadjBMI).Results. The predictive power of 8 out of 9 GRSs for obesity based on BMI remains the same for the Russian population. The predictive power of 6 GRSs for obesity based on WHRadjBMI is lower in the Russian population than in the reference sample. GRS reproducibility increases with the size of initial samples and number of variants included in the GRS increase. The use of GRSs for obesity based on BMI in the Russian population created on European populations is justified.Conclusion. For the first time in Russia, 15 obesity GRSs developed in European populations have been validated. The data obtained on the effectiveness of the considered GRS can be used in the future to improve the obesity prediction and prevention in Russia.","PeriodicalId":9545,"journal":{"name":"Cardiovascular Therapy and Prevention","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Therapy and Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15829/1728-8800-2023-3755","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Social Sciences","Score":null,"Total":0}
引用次数: 0

Abstract

Aim. To validate and evaluate the accuracy of 15 genetic risk scores (GRSs) for obesity, created in populations of European origin in the sample of two European Russia regions. Material and methods. Genetic testing has been performed using next generation sequencing on a sample from the Russian population (n=1179). The study included 15 GRS associated with body mass index (BMI) or waist-to-hip ratio adjusted for BMI (WHRadjBMI).Results. The predictive power of 8 out of 9 GRSs for obesity based on BMI remains the same for the Russian population. The predictive power of 6 GRSs for obesity based on WHRadjBMI is lower in the Russian population than in the reference sample. GRS reproducibility increases with the size of initial samples and number of variants included in the GRS increase. The use of GRSs for obesity based on BMI in the Russian population created on European populations is justified.Conclusion. For the first time in Russia, 15 obesity GRSs developed in European populations have been validated. The data obtained on the effectiveness of the considered GRS can be used in the future to improve the obesity prediction and prevention in Russia.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在俄罗斯地区人口样本中验证肥胖遗传风险评分
目的以俄罗斯两个欧洲地区为样本,验证和评估在欧洲血统人群中创建的 15 个肥胖遗传风险评分(GRS)的准确性。材料和方法。利用新一代测序技术对俄罗斯人口样本(n=1179)进行了基因检测。研究包括 15 项与体重指数(BMI)或根据体重指数调整的腰臀比(WHRadjBMI)相关的 GRS。在俄罗斯人群中,基于体重指数的 9 个 GRS 中的 8 个对肥胖的预测能力保持不变。在俄罗斯人群中,基于 WHRadjBMI 的 6 个肥胖指数的预测能力低于参考样本。随着初始样本量的增加和GRS中包含的变异体数量的增加,GRS的重现性也随之增加。在俄罗斯人群中使用基于欧洲人群体重指数的肥胖基因组测序是合理的。在俄罗斯,首次验证了在欧洲人群中开发的 15 个肥胖基因组测序。所获得的关于所考虑的肥胖风险预测系统有效性的数据可用于改善俄罗斯的肥胖预测和预防工作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cardiovascular Therapy and Prevention
Cardiovascular Therapy and Prevention Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.70
自引率
0.00%
发文量
155
审稿时长
6-12 weeks
期刊介绍: The most important objectives of the journal are: the generalization of scientific and practical achievements in the field of cardiology, increasing scientific and practical skills of cardiologists. The scientific concept of publication does the publication of modern achievements in the field of epidemiology, prevention and treatment of cardiovascular diseases, the results of research, national and international clinical trials. For publication in the journal are invited both domestic and foreign scientists and clinicians working in the field of cardiology, as well as doctors of other specialties. The magazine covers various issues in cardiology and related specialties. Each issue is prepared by Executive editor of the issue, a respected specialist in the field of epidemiology, prevention and treatment of cardiovascular diseases. The main focus of the publication — scientific articles on original research, the pharmacotherapy of cardiovascular disease, new diagnostic methods. All members of the group of authors should meet all four criteria of authorship set forth in the ICMJE recommendations: 1) concept and design development or data analysis and interpretation, and 2) manuscript justification or verification of critical intellectual content, and 3) final approval for publication of the manuscript, and 4) consent to be responsible for all aspects of the work, and assume that issues relating to the thoroughness and diligent execution of any part of the study submitted are duly investigated and resolved. Great importance the editors attached to the preparation of scientific papers by groups of authors at a high level, literacy, authors, and their ownership information, availability of research results not only to colleagues in Russia, but also abroad.
期刊最新文献
Biomarkers and subclinical left ventricular dysfunction in patients with type 2 diabetes without clinical manifestations of cardiovascular diseases Cardiovascular complications in non-cardiac surgery: what remains out of sight? Is meta-analysis the "top of the evidence pyramid" in cardiology? Consensus statement on the management of patients with asymptomatic hyperuricemia in general medical practice Multidisciplinary approach in the differential diagnosis of left ventricular hypertrophy: a case report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1